Point Biomedical Corp.

Point Biomedical Corp. is using proprietary biodegradable polymers which are adjustable for in vivo residence time, biological reactivity and tissue integration properties. The company's particular expertise is in the development and production of modified biodegradable polymers such as collagen, gelatin, and polylactide/glycolide to confer upon them desired biological activities for particular applications. But President Ron Yamamoto is careful not to describe the start-up as a “biomaterials” company. “The supply of base medical materials is a tough business. We develop application-tailored biomaterials for specific products. We feel that our design and fabrication expertise will allow us to utilize our biomaterials in medical products with unique performance advantages," says Yamamoto. The company has begun development on a number of large-market products including ultrasound contrast agents, a urological drug delivery implant, and tissue reconstruction products.

The Point biodegradable materials are especially useful for the delivery drugs, diagnostic agents, and surgical reconstruction agents. The company has...